Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
2010
MicroRNA-155 is induced during the macrophage inflammatory response
2007 StandoutNobel
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Evolution of the Cancer Stem Cell Model
2014 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
2015
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database
2009
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura
2011
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trials
2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
2008
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Mechanisms of Thrombus Formation
2008 Standout
B‐cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study
2009
Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura
2008
Helicobacter pylori-associated immune thrombocytopenia
2006
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature
2008
Contribution of platelets to tumour metastasis
2011 Standout
Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
2007
Biologic therapy in primary systemic vasculitis of the young
2009
Nucleotide signalling during inflammation
2014 StandoutNature
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Role of AID in Tumorigenesis
2007 StandoutNobel
Idiopathic thrombocytopenic purpura in elderly patients: A study of 47 cases from a single reference center
2008
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
The Oslo definitions for coeliac disease and related terms
2012 Standout
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
Long‐term follow‐up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response
2008
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia
2002
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
2009
Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future
2007
Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review
2009
B-cell depletion with rituximab in the treatment of autoimmune diseases
2007
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Helicobacter pylori Infection and Immune Thrombocytopenic Purpura: an Update
2004
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome
2010
Low Plasma Cholesterol: A Correlate of Nondiagnosed Celiac Disease in Adults With Hypochromic Anemia
1999
Use and monitoring of low dose rituximab in myasthenia gravis
2010
ANCA-associated vasculitides—advances in pathogenesis and treatment
2010
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Sarcoidosis
2013 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
New Thrombopoietic Growth Factors
2009
Inflammation and Colon Cancer
2010 Standout
Third Chinese National Consensus Report on the management of Helicobacter pylori infection1
(August 2007, Lushan, Jiangxi Province, China)
2008
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
1997 Standout
Graves' Ophthalmopathy
2010 Standout
Infections, Antigen-Presenting Cells, T Cells, and Immune Tolerance: Their Role in the Pathogenesis of Immune Thrombocytopenia
2009
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Graft-versus-host disease
2009 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Helicobacter pyloritherapy: Present and future
2012
Platelets and the immune continuum
2011 Standout
How were new medicines discovered?
2011 Standout
Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature
2007
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Toxicities of the Thrombopoietic Growth Factors
2010
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Role of Rituximab Therapy in Glomerulonephritis
2008
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long‐term follow‐up results
2008
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
TNF-α in promotion and progression of cancer
2006
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Rituximab for treatment-resistant extensive Wegener`s granulomatosis—additive effects of a maintenance treatment with leflunomide
2007
Tumour necrosis factor and cancer
2009
Cancer-related inflammation and treatment effectiveness
2014 Standout
Helicobacters and Extragastric Diseases
2009
Cancer-related inflammation
2008 StandoutNature
Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center1
2004
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies
2008
Standard triple and sequential therapies for Helicobacter pylori eradication: An update
2012
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Therapeutic expression of the platelet-specific integrin, IIb 3, in a murine model for Glanzmann thrombasthenia
2005
Association of Sarcoidosis and Immune Thrombocytopenia
2011
Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group
2006
Thrombosis as an intravascular effector of innate immunity
2012 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Anemia of Chronic Disease
2005 Standout
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: A multi‐center randomized controlled trial
2009
Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care
2003
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis
2007
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released
2007
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.
2012
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Platelet-bound lipopolysaccharide enhances Fc receptor–mediated phagocytosis of IgG-opsonized platelets
2007
The ITP syndrome: pathogenic and clinical diversity
2009
Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival
2005
Revised Response Criteria for Malignant Lymphoma
2007 Standout
2015
Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.
2007
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura
2008
Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma
2001
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
2005
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
2012
A review of the current use of rituximab in autoimmune diseases
2008
Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group
2003
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
2008
Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events
2003
Multiple Myeloma
2011 Standout
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell–mediated responses that are differentially sensitive to therapy
2009
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Fourth C hinese National Consensus Report on the management of H elicobacter pylori infection
2013
Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection
2003
Concept and classification of dystonia.
1988
Demand-adapted regulation of early hematopoiesis in infection and inflammation
2012
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Drew Provan being referenced
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults
2007
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
2006
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura
2005
Autologous 111In‐labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry
2010
ABC of Clinical haematology: Iron deficiency anaemia
1997
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP
2007
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors
1997
Infliximab chimeric antitumor necrosis factor-α monoclonal antibody as potential treatment for myelodysplastic syndromes
2005
Helicobacter pylori and Chronic ITP
2008
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
2007
Management of Immune Thrombocytopenic Purpura in Adults
2004
Red cells II: acquired anaemias and polycythaemia
2000
Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults
2002
Recent progress in understanding the pathogenesis of immune thrombocytopenia
2010
Immune thrombocytopenic purpura in adults
2007
Efficacy of mycophenolate mofetil as single‐agent therapy for refractory immune thrombocytopenic purpura
2005
Idiopathic Thrombocytopenic Purpura in Adults
2003
Long-Term Outcome of Otherwise Healthy Individuals with Incidentally Discovered Borderline Thrombocytopenia
2006
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
2009
Treatment practices in adults with chronic immune thrombocytopenia – a European perspective
2009
The safety profile of eltrombopag, a novel oral platelet growth factor, in thrombocytopenic patients and healthy subjects
2006
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review
2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation
1996
Platelets, 2nd Edition
2007
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events
2002